Anthony Mack's most recent trade in Virpax Pharmaceuticals Inc was a trade of 125,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Virpax Pharmaceuticals Inc | Anthony Mack | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Virpax Pharmaceuticals Inc | Anthony Mack | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 18 May 2022 | 75,750 | 252,562 | - | 1.3 | 101,505 | Common Stock, $0.00001 par value |
| Virpax Pharmaceuticals Inc | Anthony Mack | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 60,676 | 60,676 | - | - | Stock Option (right to buy) | |
| Virpax Pharmaceuticals Inc | Anthony Mack | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 18 Nov 2021 | 25,125 | 176,812 | - | 4.0 | 100,249 | Common Stock, $0.00001 par value |
| Virpax Pharmaceuticals Inc | Anthony Mack | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |